NucleusHealth, the parent company of teleradiology services provider StatRad, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Nucleus.io cloud software for secure medical image management.
The heart of Nucleus.io's functionality is its patented streaming technology that offers the performance of a diagnostic workstation in a web browser, NucleusHealth said. The platform is optimized for machine learning and provides flexibility and customization through numerous RESTful application programming interfaces (APIs).
The company plans to commercialize the new technology in software-as-a-service (SaaS) modules and as a platform as a service (PaaS) to enable the healthcare industry to take advantage of cloud and streaming technologies without having to decommission their current enterprise image management systems.
